Paul M. Dodd

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1999 · 729 citations

Medicine, Biostatistics, Oncology +14

Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma

Paul M. Dodd, John A. McCaffrey, Harry W. Herr et al. · Journal of Clinical Oncology · 1999 · 163 citations

Medicine, Oncology, Surgery +16

Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract

Dean F. Bajorin, John A. McCaffrey, Paul M. Dodd et al. · Cancer · 2000 · 111 citations

Medicine, Oncology, Pharmacotherapy +16

Phase I Evaluation of Sequential Doxorubicin Gemcitabine Then Ifosfamide Paclitaxel Cisplatin for Patients With Unresectable or Metastatic Transitional-Cell Carcinoma of the Urothelial Tract

Paul M. Dodd, John A. McCaffrey, Susan Hilton et al. · Journal of Clinical Oncology · 2000 · 63 citations

Medicine, Oncology, Pharmacology +17

Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma

Paul M. Dodd, John A. McCaffrey, Madhu Mazumdar et al. · Investigational New Drugs · 2000 · 23 citations

Medicine, Oncology, Pharmacology +8